A cell-targeted, payload-delivering DNA nanorobot developed at the Wyss Institute (2013) that can trigger targeted therapeutic responses. This novel technology could potentially seek out cancer cells and cause them to self-destruct
CBDC | "CBDCs, We've Been Working with Central Banks to Really Innovate And Bring Together Technology As a CBDC. Quant.Network Is Their Platform And Infrastructure That Central Banks Use to Pilot And Test CBDCs." - Gilbert Verdian (4/24/23)
Dr. Bige Deniz Unluturk 2023 - Molecular Communication Platforms at Multiple Scales Connecting Every Object To The Internet " thanks to synthetic biology, we can engineer living cells as biosensor devices and thanks to MEMS &nanotechnology...
ARPA-H POSEIDON Proposers' Day Presentation Video (9/4/24) The Platform Optimizing SynBio for Early Intervention and Detection in ONcology, or POSEIDON, program aims to fundamentally change the field of cancer screening